SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-22-012044
Filing Date
2022-06-23
Accepted
2022-06-23 16:41:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 atm_supplement.htm 424B3 14283
2 GRAPHIC img91877246_0.jpg GRAPHIC 8551
  Complete submission text file 0000950170-22-012044.txt   27211
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 424B3 | Act: 33 | File No.: 333-239538 | Film No.: 221035981
SIC: 2834 Pharmaceutical Preparations